Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 7/20 | 0.53 |
| ▸ | CCR5 | P51681 | 5/20 | 0.51 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.46 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5056837 | 0.88 | CCR5 (0.51) | OPRM1CCR5 | |
| SCHEMBL4585393 | 0.86 | CCR5 (0.53) | OPRM1CCR5 | |
| SCHEMBL4587113 | 0.85 | CCR5 (0.57) | OPRM1CCR5DRD2CACNA1B | |
| SCHEMBL4586432 | 0.83 | CCR5 (0.54) | CCR5DRD2 | |
| SCHEMBL4587621 | 0.83 | CCR5 (0.55) | OPRM1CCR5DRD2CACNA1B | |
| SCHEMBL4586335 | 0.82 | CCR5 (0.53) | CCR5DRD2CHRM2CHRM3 | |
| SCHEMBL4586715 | 0.82 | CCR5 (0.55) | OPRM1CCR5DRD2CACNA1B | |
| SCHEMBL4244496 | 0.81 | CCR5 (0.62) | CCR5 | |
| SCHEMBL5053365 | 0.79 | CCR5 (0.59) | CCR5 | |
| SCHEMBL5057871 | 0.79 | CCR5 (0.44) | CCR5CACNA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1708703-A4 | CHEMOKINE RECEPTOR BINDING COMPOUNDS | ANORMED INC (CA) | 2008-04-09 | — | — | EP | disclosed |
| EP-1708703-A2 | CHEMOKINE RECEPTOR BINDING COMPOUNDS | ANORMED INC. (CA) | 2006-10-11 | — | — | EP | disclosed |
| WO-2005059107-A2 | CHEMOKINE RECEPTOR BINDING COMPOUNDS | ANORMED INC. (CA) | 2005-06-30 | — | — | WO | disclosed |